Characteristics and outcomes according to IDH mutation status at diagnosis. (A) Comutations in patients with IDH mutation (ie, IDH1 R132, IDH2 R140, IDH2 R172) and wild-type at diagnosis (n = 125) consolidated by HSCT. (B) BM VAF at diagnosis according to IDH mutation status. (C) CIR, (D) EFS, and (E) OS of HSCT-consolidated patients with AML according to IDH mutation status.